CVS Health is reportedly closing down a number of its pharmacies installed in Target stores in the United States. The pharmacies are expected to be removed from the discount department store chain’s locations in early 2024.
As per CNN Business, the spokesperson of CVS Health confirmed the closure of its drug stores on Thursday, Jan. 11. It was said that the decision to stop its operations inside the Target outlets comes as retail pharmacy companies in the U.S. are faced with growing difficulties with their workforce, prescriptions business, and other aspects.
Schedule of the Pharmacy Shut Downs
The American retail pharmacy brand said it will close its stores in Target locations from next month until April this year. The company also said this is part of its strategy to spread out its stores and pharmacies even more. This information was shared with CNN through an email from CVS Pharmacy’s spokesperson, Amy Thibault.
The closing of the pharmacies is “based on our evaluation of changes in population, consumer buying patterns and future health needs to ensure we have the right pharmacy format in the right locations for patients,” the spokeswoman said.
Select Locations are Affected
Forbes reported that only select locations of Target stores are losing their CVS Health outlets this year. Then again, the company did not mention specific locations for the shutdown. The company is currently operating around 9,000 stores across the country.
“The pharmacy closures will begin in February and be completed by the end of April and impacted employees will be offered comparable roles within the company,” CVS Health said in a statement. “The closures are part of our plan to realign our national retail footprint and reduce store and pharmacy density and are based on our evaluation of changes in population, consumer buying patterns and future health needs to ensure we have the right pharmacy format in the right locations for patients.”
Photo by: Marques Thomas/Unsplash


Evercore Reaffirms Alphabet’s Search Dominance as AI Competition Intensifies
iRobot Files for Chapter 11 Bankruptcy Amid Rising Competition and Tariff Pressures
SoftBank Eyes Switch Inc as It Pushes Deeper Into AI Data Center Expansion
Korea Zinc Plans $6.78 Billion U.S. Smelter Investment With Government Partnership
CMOC to Acquire Equinox Gold’s Brazilian Mines in $1 Billion Deal to Expand Precious Metals Portfolio
Intel’s Testing of China-Linked Chipmaking Tools Raises U.S. National Security Concerns
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Mizuho Raises Broadcom Price Target to $450 on Surging AI Chip Demand
SK Hynix Considers U.S. ADR Listing to Boost Shareholder Value Amid Rising AI Chip Demand
Trello Outage Disrupts Users as Access Issues Hit Atlassian’s Work Management Platform
Apple App Store Injunction Largely Upheld as Appeals Court Rules on Epic Games Case
United Airlines Flight to Tokyo Returns to Dulles After Engine Failure During Takeoff
SpaceX Insider Share Sale Values Company Near $800 Billion Amid IPO Speculation
Azul Airlines Wins Court Approval for $2 Billion Debt Restructuring and New Capital Raise
Coca-Cola’s Costa Coffee Sale Faces Uncertainty as Talks With TDR Capital Hit Snag
Nomura Expands Alternative Assets Strategy With Focus on Private Debt Acquisitions
ANZ Faces Legal Battle as Former CEO Shayne Elliott Sues Over A$13.5 Million Bonus Dispute 



